Biosimilar Development Services
Product
Information
The development of biosimilar products demands an exceptional level of analytical precision and regulatory sophistication. ResolveMass Laboratories provides end-to-end analytical and bioanalytical support across all stages of the biosimilar development continuum — from early feasibility and fingerprinting studies through pivotal comparability assessments and regulatory submissions. Our comparability studies are designed and executed in alignment with ICH Q5E, FDA, and EMA biosimilar guidance frameworks, ensuring that structural, functional, and clinical data are robust, reproducible, and submission-ready. We support the full suite of analytical characterization required for biosimilar programs, including primary and higher-order structure analysis, post-translational modification...
Distribution Areas
OceaniaNorth America (USA, Canada)Middle East Region (e.g. UAE)Central America (e.g. Mexico)East Asia (e.g. China, Japan, Korea)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)South America (e.g. Brazil, Colombia)South Asia (e.g. India, Pakistan, Sri Lanka)
Supplied From
Canada
Main Categories
Biopharmaceutical ProductsContract Development and Manufacturing Organisations (CDMOs) and Contract Manufacturing Organisations (CMOs) (Services)Innovative APIsBiopharmaceutical ServicesLaboratory and Analytical Equipment (Products)
All Categories
PeptidesBiosimilarsAnalytical Chemistry (Biopharmaceutical Services)Analytical DevelopmentDevelopment & Validation of Analytical MethodsBioanalysisFormulation developmentMonoclonal AntibodiesAntibody Drug Conjugates (ADCs)
